Back to Journals » Drug Design, Development and Therapy » Volume 9

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Total article views   HTML views PDF downloads Totals
14,343 Dovepress* 12,245+ 1,938 14,183
PubMed Central* 2,098 894 2,992
Totals 14,343 2,832 17,175
*Since 15 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar